Circulation · 1960 · 28 citations · 5 references
MedicineHematologyPharmacologyCardiovascular PharmacotherapyClinical PharmacologyHemostasisAnticoagulant TherapyAnticoagulation TherapyAntithrombotic TherapyHemostatic AgentsThrombosisThrombosis PreventionAnticoagulant PharmacologyAnticoagulant-related Bleeding ComplicationsAnticoagulation-related HemorrhageAntithrombotic-associated BleedingDrug-related HemorrhageHemorrhagic ManifestationsHemorrhagic PresentationIntravascular Hemolysis
alpha-acetonylbelizyl) -4-hydroxyeoumarin sodium, (Coumadini) is onie of several popular anti- coagulant agents used to delay intravascular clotting by depressioni of the prothrombin level of the blood. This drug is often used iu instances in which there is an acute throin- bophlebitis, pulmoniary and peripheral embo- lism, eoronary and cerebral thrombosis, and it is employed prophylactically to prevent arterial einbolizationi and thrombosis. 1-4 Excessive lowering of eirculatinig prothromn- bin with spontaneous hemorrhage is the im- portant complication in the use of this prothrombinemic agent.4' 5 Five per cent of the patients who receive anticoagulant ther- apy develop mild hemorrhagic nmanifestations such as hematuria, hemoptysis, epistaxis, anid ecehymosis. These are readily controlled by the administration of vitamiin K,. Approxi- mately 2 per cent of patients develop more severe hemorrhagic phenomena such as hem- arthrosis, gastrointestinal, cerebral, or sub-
5
Victor A. Drill · The American Journal of the Medical Sciences · 1955 · 149 citations
Lloyd W. Hazleton, Heini Murer, R. Thiessen et al. · PubMed · 1956 · 95 citations
SUICIDE ATTEMPT WITH WARFARIN, A BISHYDROXYCOUMARIN-LIKE RODENTICIDE
Roy W. Holmes · JAMA · 1952 · 52 citations